(Q36740438)

16 August 2017

Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha (English)

1 reference

16 August 2017

1 reference

Kesavan Esuvaranathan

1

1 reference

16 August 2017

Edmund Chiong

2

1 reference

16 August 2017

Thomas Paulraj Thamboo

3

1 reference

16 August 2017

Yiong Huak Chan

4

1 reference

16 August 2017

Revathi Kamaraj

5

1 reference

16 August 2017

Ratha Mahendran

6

1 reference

16 August 2017

Ming Teh

7

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

16 August 2017

1 reference

16 August 2017

109

1 reference

16 August 2017

1097-1105

1 reference

16 August 2017

6

1 reference

p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder

16 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

Superficial bladder cancer: progression and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

P53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

p53 Expression Predicts Progression and Poor Survival in T1 Bladder Tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Pretreatment p53 nuclear overexpression as a prognostic marker in superficial bladder cancer treated with Bacillus Calmette-Guérin (BCG).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Long-term efficacy of intravesical bacillus Calmette-Guerin for carcinoma in situ: relationship of progression to histological response and p53 nuclear accumulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Correlation between p53 over expression and response to bacillus Calmette-Guerin therapy in a high risk select population of patients with T1G3 bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Guérin therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

p53 status does not predict initial clinical response to bacillus Calmette-Guerin intravesical therapy in T1 bladder tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional-cell bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

An immunohistochemical study of p53 protein in the different histological subtypes of gastric carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

p53 expression in hepatocellular carcinoma in a population in Singapore with endemic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

An immunohistochemical study of p53 protein in cervical intraepithelial neoplasia and squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

An immunohistochemical study of p53 protein in ovarian mucinous neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22503

7 January 2021

Identifiers

DOI

10.1002/CNCR.22503

1 reference

16 August 2017

1 reference